is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
2020 has redefined disruption. But it has also brought out the collective spirit of the pharma industry as new partnerships were created, new ways of dealing with challenges were discovered.
Faced with the task of finding a vaccine for COVID-19, while keeping up the supply of lifesaving drugs with a severely strained supply chain, the pharma industry has shown incredible resilience.
We’re looking forward to continuing to drive our industry forward, connect our communities and support businesses, together. Be sure to sign up to get notified when CPhI North America 2021 registration opens!
No matter where you are in the pharmaceutical supply chain, CPhI North America’s expo hall has you covered. It’s an expansive marketplace uniting pharma buyers and sellers, strategically positioned in seven unique zones.
Biopharma comprises 25% of the total pharma market and revenues have gone up by over 6000% from the 1990s to now. What are companies doing to keep up with this growth and innovation? Read this article to find out.
How is biopharma striking a balance between modernizing drug development & delivery and the effort to rein in R&D expenses? While change is unlikely to be quick, there is consensus that pharma does need to embrace changes in drug development and delivery fully explore the wide range of opportunities that exist.
Pipeline diversification, emerging therapies and shifting customer demands are the real dynamics reshaping the contract manufacturing market, according to experts. Almost every article written about contracting reports that demand for outsourced manufacturing services is growing and states that the CDMO sector is consolidating.